Monday, December 23, 2024

Karmanos Cancer Institute invests in software to identify and manage patients at high risk of developing breast cancer

The Barbara Ann Karmanos Cancer Institute, a leading breast cancer prevention and care provider, has adopted Volpara Risk Pathways, a market-leading software program designed to simplify risk assessment and patient management for various cancers, including breast, lung, ovarian, and colorectal cancer. This new preventative tool has been implemented as part of Karmanos’ high-risk breast cancer program. It is available to patients receiving a screening or diagnostic mammogram at the Women’s Wellness Clinic in Karmanos Cancer Center in Detroit and at the Karmanos Cancer Institute – Lawrence and Idell Weisberg Cancer Center in Farmington Hills.

According to the American Cancer Society, one in eight women is diagnosed with breast cancer during their lifetime. Breast cancer is predicted to be the second leading cause of cancer death in women. This makes it imperative for women to not only receive regular mammography screenings but, together with their healthcare providers, understand their risk of developing breast cancer so they can be triaged to additional care if necessary.

Also Read: Lightbeam Health Solutions Announces Platform Migration to Microsoft Azure SQL Database

“The biggest danger with high-risk breast cancer patients is that they don’t know they’re high-risk,” said Eric Brown, M.D., FACS, surgical oncologist and co-leader of the Breast Cancer Multidisciplinary Team (MDT) at Karmanos. Dr. Brown has been implementing Volpara’s program in his everyday practice. He believes this system will help identify more women and allow the Women’s Wellness Clinic experts to recommend the best course of prevention for each patient.

“Breast cancer risk assessment is a priority for Karmanos in our effort to enable early cancer detection. Volpara allows us to inform patients of their risk and provide the care that is right for them,” added Dr. Brown.

The patient plays a significant role in their risk assessment by providing personal and family health history details. These details include who in their immediate family has had certain cancers and when they were diagnosed with those cancers. When patients make an appointment at Karmanos for their mammography screening, they will receive an invite by email and text message to complete the assessment before their screening appointment.

SOURCE: PR Newswire

Subscribe Now

    Hot Topics